Researchers investigate how short-term exposure to ambient air pollution and temperature affects bronchiectasis mortality ...

You are half as likely to die from lung cancer than a person who is still smoking. Your risk of cancer of the pancreas and kidney decreases. Your risk of coronary heart disease is the same as someone ...

Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Insmed (INSM – Research Report) yesterday and set a price target ...

The mucus is a common symptom in chronic lung diseases such as COPD ( chronic bronchitis and emphysema), cystic fibrosis, bronchiectasis, NTM lung disease, or asthma. Besides ailments related to lungs ...

Insmed sees growth with ARIKAYCE and upcoming Brensocatib approval. Find out why INSM stock is a strong pick with significant ...

NOVEMBER 19, 2024 — UTSA faculty are leveraging their expertise to fight Mycobacterium tuberculosis (Mtb), the germ ...

During the 1990s, medicinal chemist Anders Hallberg was working in his lab at the Department of Medicinal Chemistry. He was exploring a hormonal system in the body that regulates blood pressure, among ...

Apr. 11, 2024 — Although lung cancer is traditionally thought of as a 'smoker's disease,' a surprising 15-20% of newly diagnosed lung cancers occur in people who have never smoked, many of whom ...

USA-based Paratek Pharmaceuticals has released positive top-line data from a Phase IIb trial evaluating its oral antibiotic ...

In a study of 66 adult patients with nontuberculous mycobacteria pulmonary disease (NTM-PD) caused by mycobacterium abscessus ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.